Litcius/Paper detail

Efficacy and safety of immune checkpoint inhibitors in elderly patients with metastatic renal cell carcinoma

Yuki Nemoto, Hiroki Ishihara, Kazutaka Nakamura, Hidekazu Tachibana, Hironori Fukuda, Kazuhiko Yoshida, Hirohito Kobayashi, Junpei Iizuka, Hiroaki Shimmura, Yasunobu Hashimoto, Kazunari Tanabe, Tsunenori Kondo, Toshio Takagi

2021International Urology and Nephrology18 citationsDOI

Topics & Concepts

NivolumabMedicineIpilimumabInternal medicineRenal cell carcinomaAdverse effectIncidence (geometry)NephrologyOncologyGastroenterologyImmunotherapyCancerPhysicsOpticsRenal cell carcinoma treatmentCancer Immunotherapy and BiomarkersFerroptosis and cancer prognosis
Efficacy and safety of immune checkpoint inhibitors in elderly patients with metastatic renal cell carcinoma | Litcius